title: A comparison of the functionality and in vivo phenotypic stability of cartilaginous tissues engineered from different stem cell sources.
abstract: Joint-derived stem cells are a promising alternative cell source for cartilage repair therapies that may overcome many of the problems associated with the use of primary chondrocytes (CCs). The objective of this study was to compare the in vitro functionality and in vivo phenotypic stability of cartilaginous tissues engineered using bone marrow-derived stem cells (BMSCs) and joint tissue-derived stem cells following encapsulation in agarose hydrogels. Culture-expanded BMSCs, fat pad-derived stem cells (FPSCs), and synovial membrane-derived stem cells (SDSCs) were encapsulated in agarose and maintained in a chondrogenic medium supplemented with transforming growth factor-β3. After 21 days of culture, constructs were either implanted subcutaneously into the back of nude mice for an additional 28 days or maintained for a similar period in vitro in either chondrogenic or hypertrophic media formulations. After 49 days of in vitro culture in chondrogenic media, SDSC constructs accumulated the highest levels of sulfated glycosaminoglycan (sGAG) (∼2.8% w/w) and collagen (∼1.8% w/w) and were mechanically stiffer than constructs engineered using other cell types. After subcutaneous implantation in nude mice, sGAG content significantly decreased for all stem cell-seeded constructs, while no significant change was observed in the control constructs engineered using primary CCs, indicating that the in vitro chondrocyte-like phenotype generated in all stem cell-seeded agarose constructs was transient. FPSCs and SDSCs appeared to undergo fibrous dedifferentiation or resorption, as evident from increased collagen type I staining and a dramatic loss in sGAG content. BMSCs followed a more endochondral pathway with increased type X collagen expression and mineralization of the engineered tissue. In conclusion, while joint tissue-derived stem cells possess a strong intrinsic chondrogenic capacity, further studies are needed to identify the factors that will lead to the generation of a more stable chondrogenic phenotype.
authors.affiliation: Trinity Centre for Bioengineering, Trinity Biomedical Sciences Institute, Dublin 2, Ireland.
authors.forename: Tatiana
authors.initials: T
authors.lastname: Vinardell
authors.forename: Eamon J
authors.initials: EJ
authors.lastname: Sheehy
authors.forename: Conor T
authors.initials: CT
authors.lastname: Buckley
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Kelly
mesh_terms: D000273:Adipose Tissue / Q000166:cytology; D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology; D002356:Cartilage / Q000187:drug effects / Q000502:physiology*; D019902:Chondrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D020219:Chondrogenesis / Q000187:drug effects; D003094:Collagen / Q000378:metabolism; D003470:Culture Media / Q000494:pharmacology; D055119:Elastic Modulus / Q000187:drug effects; D006025:Glycosaminoglycans / Q000378:metabolism; D006984:Hypertrophy; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D010641:Phenotype; D012685:Sepharose / Q000494:pharmacology; D013194:Staining and Labeling; D013234:Stem Cells / Q000166:cytology*; D034421:Sus scrofa; D013583:Synovial Membrane / Q000166:cytology; D023822:Tissue Engineering / Q000379:methods*
chemical_list: D003470:Culture Media; D006025:Glycosaminoglycans; C013786:A73025; D003094:Collagen; D012685:Sepharose